Clouder
Founders: Tomi Grönlund, Emma Grönlund
We are a sector agnostic early-stage (pre-seed and seed) investor that wants to partner with founders from the very beginning of their journey and support them throughout their growth. Our team has global experience in building and scaling companies both as founders and in various CxO roles. We invest in ambitious and determined teams that can one day become industry leaders.
The Finnish online furniture store Mjuk has raised a €2.5 million funding round, in which Trind VC, Alliance VC, Superhero Capital, Lifeline Ventures, and a number of angel investors participated.
Read moreMjuk is an end to end marketplace for quality second-hand furniture and design. We provide a seamless selling experience to both consumers and companies by handling both logistics and marketing. With a curated selection of quality furniture and added services the buying experience rivals any top ecommerce brand.
CEO: Rickard Zilliacus
Founders: Rickard Zilliacus, Max Heino, Casper von Pfaler
Measurlabs raised and completed a 2.5M€ Seed round to fuel its growth.
Read moreMeasurlabs provides laboratory analyses and testing services for all kinds of materials and products. We combine the best methods from hundreds of laboratories in one service and make it incredibly easy to buy laboratory analyses for complicated materials and products.
CEO: Teemu Myllymäki
Founders: Teemu Myllymäki, Kalle Lagerblom
Norsepower raises EUR28M financing round to bring sails back to shipping.
Read moreNorsepower was founded in late 2012 with a mission to reduce the environmental impact of shipping by providing efficient, easy to use, and reliable auxiliary wind propulsion for ships – through its Rotor Sail Solution technology. The company’s vision is to maintain the market leader position in a growing market for auxiliary wind propulsion systems for large ships.
CEO: Tuomas Riski
Founders: Jarkko Väinämö, Tuomas Riski
Lifeline Ventures led the Series A round in TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, with the final close of
EUR 22 million.
TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. Advanced solid tumors are difficult to treat with limited treatment options available. However, preclinical data on TILT® technology, alone and in combination with other immunotherapy agents have demonstrated 100% cure rates.
CEO: Akseli Hemminki
Founder: Akseli Hemminki